Acyldepsipeptide antibiotics

Last updated December 29, 2023

Acyldepsipeptide or cyclic acyldepsipeptide (ADEP) is a class of potential antibiotics first isolated from bacteria and act by deregulating the ClpP protease. Natural ADEPs were originally found as products of aerobic fermentation in Streptomyces hawaiiensis , A54556A and B,^[1] and in the culture broth of Streptomyces species, enopeptin A and B.^[2] ADEPs are of great interest in drug development due to their antibiotic properties and thus are being modified in attempt to achieve greater antimicrobial activity.^[3]^[4]

The potential role of ADEPs in combating antibiotic drug resistance is postulated due to their novel mode of action that other antibiotics are not known to use, activation of casein lytic protease (ClpP) which is an important bacterial protease.^[5]^[6] Most antibiotics work through inhibitory processes to establish cell death, while ADEPs actually work through activation of the protease to cause uncontrolled protein degradation, inhibition of cell division, and subsequent cell death.^[3]^[4]^[7] They largely affect Gram-positive bacteria ^[4] and could be of great use to target antibiotic resistant microbes such as methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP), Mycobacterium tuberculosis , and others.^[3]^[4] Despite the potential use of ADEP, possible resistance has been examined in certain species.^[8]

Chemical structures of natural ADEPs

Enopeptin A
Enopeptin B
A54556A
A54556B

Mechanism

ADEP antibiotics can be used to defeat resistant bacterial infections. They bind to ClpP and allow the protease to degrade proteins without the help of an ATPase.^[6]^[9]^[10] ADEP4/ClpP complexes target primarily newly formed proteins, and FtsZ which allows cell division. ClpP active form is a tetradecamer composed of two heptamers to which 14 ADEPs bind to.^[6]

ADEPs bind in the cavities formed by two ClpP monomers.^[6]^[11] Their binding site is composed of hydrophobic residues and corresponds to the binding sites of ClpP ATPases. Upon binding, a series of secondary structures shifts occur from the outer region to the center of ClpP. This puts the flexible N-terminal β-loop, into a disordered state. The β-loops normally form a gate above the proteolytic channel and prevent proteins from randomly passing through. They are critical for ClpP interaction with its substrate and ATPases. When ADEP binds, the β-loops shift outward and this is accompanied by the shifts of two α-helices (α1 and α2), four β-strands (β1, β2, β3 and β5) and other loops which lead to the opening of the ClpP pore. In summary, ADEP4 deregulates ClpP function and changes it from a closed state to an open one. At this point its specific proteolytic activity becomes a less controlled process, with the destruction of proteins that are around in the targeted cell.

The peptidase ClpP is highly conserved throughout organisms and is tightly regulated.^[4] Without activation, ClpP in normal conditions can degrade short peptides that freely diffuse into its inner degradation chamber.^[12] Clp-family proteins are ATP-dependent proteases which play a crucial role in the cell function by degrading misfolded proteins.^[9] ClpP is a monomer on its own but oligomerizes into tetradecamers when bound to ATPases.^[13] It needs an ATPase to identify, unfold, and transfer targeted big proteins into its proteolytic channel.^[6]^[9]^[11] In fact, ClpP on its own can only degrade peptides that are up to six amino acids long.^[13] ADEP binding induces ClpP proteolytic activation that leads to the proteins degradation in the cell, especially nascent proteins and the Ftsz protein which is an important protein in cell division.^[6]^[9] This potentially leads to cell death and is the reason why ADEP is a promising technique for drug development.

For folded proteins, unfolded proteins, and long peptides, ClpP must be activated by a protein in the family of ATPase associated with diverse cellular activities (AAA proteins), such as ClpA, ClpX, or ClpC.^[12] These chaperone proteins are responsible for hydrolyzing ATP to ADP, harnessing the energy, and then taking folded proteins and unfolding them.^[14] Next, Clp-ATPases slip the unfolded proteins into the degradation chamber within ClpP, allowing for processive degradation of the substrate.^[12]^[15] This process is tightly regulated with the hydrolysis of ATP to prevent uncontrolled protein or peptide degradation that would be harmful to the cell.^[4]

In contrast, ADEP activates ClpP without the need for ATP hydrolysis, causing degradation of unfolded proteins and peptides within the cell at uncontrolled rates.^[12] ADEPs are thought to bind slightly cooperatively on the surface of each ClpP ring in its hydrophobic pockets and have allosteric effects in activation of ClpP.^[12] This binding initiates ClpP to undergo a conformational change such that its N-terminal region opens up its axial pore to allow for partial degradation of products, as compared to progressive degradation with ClpA.^[12] ADEP activation of ClpP does not allow for folded protein degradation, but even with unfolded protein and peptide degradation, ADEP still causes bacterial cell death.^[12]

Research has shown that ADEP-activated ClpP targets cell division rather than metabolic processes.^[7] ADEP appears to initiate ClpP to preferably degrade FtsZ, an important bacterial protein involved in septum formation that is necessary for bacterial cell division.^[7] As a result, Gram-positive bacteria treated with ADEPs form long filaments before cell death.^[4]^[7]

Advantages

When bacteria are exposed to antibiotics they can become resistant or tolerant to the antibiotic. ADEPs have a great potential for clinical application due to their high antibacterial activity against Gram-positive pathogens such as Staphylococcus aureus, and other pathogens that are found in biofilms and chronic infections. Their effectiveness increases when combined with different antibiotics such as ciprofloxacin, linezolid, vancomycin or rifampicin.^[9] Additional studies should focus more on the toxicity of ADEPs and their implementation for clinical use.

Applications

After the dysregulation of bacterial proteolytic machinery by a new class of antibiotics was published in the Journal Nature, many scientists started to study this antibiotic. Most of the experiments are focused on how the ADEPs/ClpP complex work, and the functional difference between ADEP and its synthetic congeners.^{[ citation needed ]}

In 2011, P. Sass and co-workers performed a research focusing in the interaction and function of ADEPs and ClpP. They induced ADEP into Bacillus subtilis, Staphylococcus aureus and Streptococcus pneumoniae to identify how ADEP leads to the death of bacteria.^[16] The results demonstrated that ADEP is perturbing bacterial cell division. To identify the reason why ADEP inhibited cell division, researchers monitored septum formation and nucleoid segregation in ADEP B. subtilis and ADEP S. aureus. The S. aureus and B. subtilis samples gave equivalent results. This part showed the importance of wild type of ClpP and inhibition of septum formation is by direct interference of ADEP with the cell division components. Localization studies by GFP-labeled cell divisions proteins demonstrated that ADEP causes delocalization of Ftsz and inhibition of Z-Ring assembly in both species. The impact of ADEP in ∆clpX mutant indicated that ADEP is affecting cell division and that it also inhibits Z-ring assembly. Finally researchers repeat the experiment with ∆ClpP mutant to confirm that the presence of ADEP decreases abundance of FtsZ through ClpP degradation.^{[ citation needed ]}

In 2013, scientists at Northeastern University performed an experiment focused on how ADEP 4/ClpP works.^[9] The experimental results showed the efficiency of ADEP4 when it is combined with other antibiotics. Researchers monitored the amount of trypic peptides, and found out that ADEP4/ClpP induces peptide degradation in a biofilm system. By using Mueller-Hinton broth they demonstrated that ADEP 4 was more effective than other antibiotics such as rifampicin or vancomycin. However, they observed the same trends where ADEP4 combined to rifampicin is more effective and actually eradicates all stationary phases. The in vitro results showed the efficiency of ADEP 4 in mice infected with 4 different strains S. aureus, the laboratory strain SA113, and clinical isolates USA300, UAMS-1 and strain 37.^{[ citation needed ]}

Chemistry

ADEPs are naturally occurring antibiotics. Certain bacteria produce them as defense mechanism in antagonist bacterial interactions.^[17] For instance, Streptomyces species produce them as secondary metabolites.^[18]

There are 6 forms of acyl depsipeptides that are distinguishable by their chemical structure and function.^[13] ADEPs generally differ by one or two functional groups that give some of them more flexibility, and stability.^[10] Their chemical structures are derived from ADEP 1 and are slightly different from one another.^[6]^[13] For instance, the only difference between ADEP 2 and ADEP 3 is the conformation of the difluorophenylalanine side chain. ADEP 2 has an S configuarion while ADEP 3 has an R configuarion.^[10]

Molecular modification

In order to develop a useful antibiotic, ADEP continues to be modified for greater antimicrobial activity and stability. By restricting components of ADEP to decrease the molecule's flexibility, binding was enhanced and antimicrobial activity significantly increased.^[3] Specific amino acids essential to the peptidolactone core of ADEP were altered and restricted, causing stabilization of ADEP in a bioactive conformation.^[3] In fact, the conformational restrictions of ADEP resulted in its ability to activate ClpP increasing seven-fold and its antimicrobial activity 1200-fold.^[3] Research on altering ADEP molecules continues in attempt to construct a new antibiotic for public use.^{[ citation needed ]}

Related Research Articles

Proteolysis is the breakdown of proteins into smaller polypeptides or amino acids. Uncatalysed, the hydrolysis of peptide bonds is extremely slow, taking hundreds of years. Proteolysis is typically catalysed by cellular enzymes called proteases, but may also occur by intra-molecular digestion.

Proteasomes are protein complexes which degrade unneeded or damaged proteins by proteolysis, a chemical reaction that breaks peptide bonds. Enzymes that help such reactions are called proteases.

A protease is an enzyme that catalyzes proteolysis, breaking down proteins into smaller polypeptides or single amino acids, and spurring the formation of new protein products. They do this by cleaving the peptide bonds within proteins by hydrolysis, a reaction where water breaks bonds. Proteases are involved in numerous biological pathways, including digestion of ingested proteins, protein catabolism, and cell signaling.

A transmembrane protein is a type of integral membrane protein that spans the entirety of the cell membrane. Many transmembrane proteins function as gateways to permit the transport of specific substances across the membrane. They frequently undergo significant conformational changes to move a substance through the membrane. They are usually highly hydrophobic and aggregate and precipitate in water. They require detergents or nonpolar solvents for extraction, although some of them (beta-barrels) can be also extracted using denaturing agents.

In biology and biochemistry, protease inhibitors, or antiproteases, are molecules that inhibit the function of proteases. Many naturally occurring protease inhibitors are proteins.

AAAproteins are a large group of protein family sharing a common conserved module of approximately 230 amino acid residues. This is a large, functionally diverse protein family belonging to the AAA+ protein superfamily of ring-shaped P-loop NTPases, which exert their activity through the energy-dependent remodeling or translocation of macromolecules.

Filamentation is the anomalous growth of certain bacteria, such as Escherichia coli, in which cells continue to elongate but do not divide. The cells that result from elongation without division have multiple chromosomal copies.

Penicillin-binding proteins (PBPs) are a group of proteins that are characterized by their affinity for and binding of penicillin. They are a normal constituent of many bacteria; the name just reflects the way by which the protein was discovered. All β-lactam antibiotics bind to PBPs, which are essential for bacterial cell wall synthesis. PBPs are members of a subgroup of enzymes called transpeptidases. Specifically, PBPs are DD-transpeptidases.

<span class="mw-page-title-main">Endopeptidase Clp</span>

Endopeptidase Clp (EC 3.4.21.92, endopeptidase Ti, caseinolytic protease, protease Ti, ATP-dependent Clp protease, ClpP, Clp protease). This enzyme catalyses the following chemical reaction

The heat shock proteins HslV and HslU are expressed in many bacteria such as E. coli in response to cell stress. The hslV protein is a protease and the hslU protein is an ATPase; the two form a symmetric assembly of four stacked rings, consisting of an hslV dodecamer bound to an hslU hexamer, with a central pore in which the protease and ATPase active sites reside. The hslV protein degrades unneeded or damaged proteins only when in complex with the hslU protein in the ATP-bound state. HslV is thought to resemble the hypothetical ancestor of the proteasome, a large protein complex specialized for regulated degradation of unneeded proteins in eukaryotes, many archaea, and a few bacteria. HslV bears high similarity to core subunits of proteasomes.

A depsipeptide is a peptide in which one or more of its amide, -C(O)NHR-, groups are replaced by the corresponding ester, -C(O)OR-. Many depsipeptides have both peptide and ester linkages. Elimination of the N–H group in a peptide structure results in a decrease of H-bonding capability, which is responsible for secondary structure and folding patterns of peptides, thus inducing structural deformation of the helix and β-sheet structures. Because of decreased resonance delocalization in esters relative to amides, depsipeptides have lower rotational barriers for cis-trans isomerization and therefore they have more flexible structures than their native analogs. They are mainly found in marine and microbial natural products.

In enzymology, arginine kinase is an enzyme that catalyzes the chemical reaction

ATP-dependent Clp protease proteolytic subunit (ClpP) is an enzyme that in humans is encoded by the CLPP gene. This protein is an essential component to form the protein complex of Clp protease.

Aureolysin is an extracellular metalloprotease expressed by Staphylococcus aureus. This protease is a major contributor to the bacterium's virulence, or ability to cause disease, by cleaving host factors of the innate immune system as well as regulating S. aureus secreted toxins and cell wall proteins. To catalyze its enzymatic activities, aureolysin requires zinc and calcium which it obtains from the extracellular environment within the host.

ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial is an enzyme that in humans is encoded by the CLPX gene. This protein is a member of the family of AAA Proteins and is to form the protein complex of Clp protease.

Heike Brötz-Oesterhelt is a German microbiologist. She is a full professor and holds the Chair of the Department for Microbial Bioactive Compounds at the Interfaculty Institute for Microbiology and Infection Medicine, University of Tübingen, Germany.

Bacterial secretion systems are protein complexes present on the cell membranes of bacteria for secretion of substances. Specifically, they are the cellular devices used by pathogenic bacteria to secrete their virulence factors to invade the host cells. They can be classified into different types based on their specific structure, composition and activity. Generally, proteins can be secreted through two different processes. One process is a one-step mechanism in which proteins from the cytoplasm of bacteria are transported and delivered directly through the cell membrane into the host cell. Another involves a two-step activity in which the proteins are first transported out of the inner cell membrane, then deposited in the periplasm, and finally through the outer cell membrane into the host cell.

FtsK is a protein in E.Coli involved in bacterial cell division and chromosome segregation. It is one of the largest proteins, consisting of 1329 amino acids. FtsK stands for "Filament temperature sensitive mutant K" because cells expressing a mutant ftsK allele called ftsK44, which encodes an FtsK variant containing an G80A residue change in the second transmembrane segment, fail to divide at high temperatures and form long filaments instead. FtsK, specifically its C-terminal domain, functions as a DNA translocase, interacts with other cell division proteins, and regulates Xer-mediated recombination. FtsK belongs to the AAA superfamily and is present in most bacteria.

Kim Lewis is an American researcher, author and academic. He is a University Distinguished Professor and the director of Antimicrobial Discovery Center at Northeastern University.

Alfred Lewis Goldberg was an American cell biologist-biochemist and professor at Harvard University. His major discoveries have concerned the mechanisms and physiological importance of protein degradation in cells. Of wide impact have been his lab's demonstration that all cells contain a pathway for selectively eliminating misfolded proteins, his discoveries about the role of proteasomes in this process and of the enzyme systems catalyzing protein breakdown in bacteria, his elucidating the mechanisms for muscle atrophy and the role of proteasomes in antigen presentation to the immune system, and his introduction of proteasome inhibitors now widely used as research tools and in the treatment of blood cancers.

References

↑ K. H. Michel, R. E. Kastner (Eli Lilly and Company), US 4492650, 1985 [Chem. Abstr. 1985, 102, 130459].
↑ Osada, Hiroyuki; Yano, Tatsuya; Koshino, Hiroyuki; Isono, Kiyoshi (1991). "Enopeptin A, a novel depsipeptide antibiotic with anti-bacteriophage activity". The Journal of Antibiotics. 44 (12): 1463–1466. doi: 10.7164/antibiotics.44.1463 . PMID 1778798.
1 2 3 4 5 6 Carney, Daniel W.; Schmitz, Karl R.; Truong, Jonathan V.; Sauer, Robert T.; Sello, Jason K. (2014). "Restriction of the Conformational Dynamics of the Cyclic Acyldepsipeptide Antibiotics Improves Their Antibacterial Activity". Journal of the American Chemical Society. 136 (5): 1922–1929. doi: 10.1021/ja410385c . PMC 4004210 . PMID 24422534.
1 2 3 4 5 6 7 Hinzen, Berthold; Labischinski, Harald; Brötz-Oesterhelt, Heike; Endermann, Rainer; Benet-Buchholz, Jordi; Hellwig, Veronica; Häbich, Dieter; Schumacher, Andreas; Lampe, Thomas; Paulsen, Holger; Raddatz, Siegfried (2006). "Medicinal Chemistry Optimization of Acyldepsipeptides of the Enopeptin Class Antibiotics". ChemMedChem. 1 (7): 689–693. doi:10.1002/cmdc.200600055. PMID 16902918. S2CID 36525372.
↑ Brötz-Oesterhelt, Heike; Beyer, D.; Kroll, H.P.; Enderman, R.; Ladel, C.; Schroeder, W.; Hinzen, B.; Raddatz, S.; Paulsen, H.; Henniger, K.; Bandow, J.E.; Sahl, H.G.; Labischinski, H. (2 October 2005). "Dysregulation of bacterial proteolytic machinery by a new class of antibiotics". Nature Medicine. 11 (10): 1082–1087. doi:10.1038/nm1306. PMID 16200071. S2CID 661201.
1 2 3 4 5 6 7 Lee, BG; Park, EY; Lee, KE; Jeon, H; Sung, KH; Paulsen, H; Rübsamen-Schaeff, H; Song, HK (2010). "Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism". Nature Structural & Molecular Biology. 17 (4): 471–8. doi:10.1038/nsmb.1787. PMID 20305655. S2CID 20029980.
1 2 3 4 Sass, Peter; Josten, Michaele; Famulla, Kirsten; Schiffer, Guido; Sahi, Hans-Georg; Hamoen, Leendert; Brotz-Oesterhelt, Heike (2011). "Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ". PNAS. 108 (42): 17474–17479. Bibcode:2011PNAS..10817474S. doi: 10.1073/pnas.1110385108 . PMC 3198362 . PMID 21969594.
↑ Gominet, M.; Seghezzi, N.; Mazodier, P. (2011). "Acyl depsipeptide (ADEP) resistance in Streptomyces". Microbiology. 157 (8): 2226–2234. doi: 10.1099/mic.0.048454-0 . PMID 21636652.
1 2 3 4 5 6 Conlon, B.P; Nakayasu, E. S.; Fleck, L. E.; LaFleur, M. D.; Isabella, V. M.; Coleman, K.; Leonard, S. N.; Smith, R. D.; Adkins, J. N.; Lewis, K. (21 November 2013). "Activated ClpP kills persisters and eradicates a chronic biofilm infection". Nature. 503 (7476): 365–370. Bibcode:2013Natur.503..365C. doi:10.1038/nature12790. PMC 4031760 . PMID 24226776.
1 2 3 Hinzen, B.; Raddatz, S.; Paulsen, H.; Lampe, T.; Schumacher, A.; Häbich, D.; Hellwig, V.; Bennet-Buchholz, J.; Endermann, R.; Labischinski, H.; Brötz-Oesterhelt, H. (10 July 2006). "Medical Chemistry Optimization of Acyldepsipeptides of the Enopeptin Class Antibiotics". ChemMedChem. 1 (7): 689–693. doi:10.1002/cmdc.200600055. PMID 16902918. S2CID 36525372.
1 2 Li, D.H.; Chung YS; Gloyd M; Joseph E; Ghirlando R; Wright GD; Cheng YQ; Maurizi MR; Guarné A; Ortega J. (24 September 2010). "Acyldepsipeptide Antibiotics Induce the Formation of a Structured Axial Channel in ClpP: A Model for the ClpX/ClpA-Bound State of ClpP". Chemistry & Biology. 17 (9): 959–969. doi:10.1016/j.chembiol.2010.07.008. PMC 2955292 . PMID 20851345.
1 2 3 4 5 6 7 Li; Him Shun, Dominic; Guarné, Alba; Maurizi, Michael R.; Cheng, Yi-Qiang; Wright, Gerard D.; Ghirlando, Rodolfo; Joseph, Ebenezer; Gloyd, Melanie; Seon Chung, Yu; Ortega, Joaquin (2010). "Acyldepsipeptide Antibiotics Induce The Formation Of A Structured Axial Channel In ClpP: A Model For The ClpX/ClpA-Bound State Of ClpP". Chemistry & Biology. 17 (9): 959–969. doi:10.1016/j.chembiol.2010.07.008. PMC 2955292 . PMID 20851345.
1 2 3 4 Kirstein, J.; Hoffmann A; Lilie H; Schmidt R; Rübsamen-Waigmann H; Brötz-Oesterhelt H; Mogk A; Turgay K (2009-03-26). "The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease". EMBO Molecular Medicine. 1 (1): 37–49. doi:10.1002/emmm.200900002. PMC 3378108 . PMID 20049702. Accessed 2016-04-06.
↑ Hoskins, J. R. (1998). "The role of the ClpA chaperone in proteolysis by ClpAP". Proceedings of the National Academy of Sciences. 95 (21): 12135–12140. Bibcode:1998PNAS...9512135H. doi: 10.1073/pnas.95.21.12135 . PMC 22797 . PMID 9770452.
↑ Ishikawa, T.; Beuron, F.; Kessel, M.; Wickner, S.; Maurizi, M.; Steven, A. (2001). "Translocation pathway of protein substrates in ClpAP protease". Proceedings of the National Academy of Sciences. 98 (8): 4328–4333. Bibcode:2001PNAS...98.4328I. doi: 10.1073/pnas.081543698 . PMC 31834 . PMID 11287666.
↑ Sass, Peter; Josten, Michaele; Famulla, Kirsten; Schiffer, Guido; Sahl, Hans-Georg; Ha, Leendert; Börtz-Oesterhelt, Heike (2011). "Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ". Proceedings of the National Academy of Sciences of the United States of America. 108 (42): 17474–17479. Bibcode:2011PNAS..10817474S. doi: 10.1073/pnas.1110385108 . PMC 3198362 . PMID 21969594.
↑ Stacey, Kevin. "Clever chemistry and a new class of antibiotics". Brown University. Retrieved 2014-03-15.
↑ Xu, S.; Guo, P.; Gao, Y.; Shi, Q.; He, D.; Gao, Y.; Zhang, H. (2013). "Acyldepsipeptides inhibit the growth of renal cancer cells through G1 phase cell cycle arrest". Biochemical and Biophysical Research Communications. 438 (3): 468–472. doi:10.1016/j.bbrc.2013.07.119. PMID 23928161.